Actively Recruiting
Nurse Follow-up to Reduce Inappropriate Emergency Department Use in Adult Patients with Ambulatory Sensitive Conditions in CMSL Study 2
Led by Geisinger Clinic · Updated on 2026-02-11
12990
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate a nurse-led intervention designed to reduce unnecessary emergency department visits among adult patients diagnosed with ambulatory sensitive conditions (ASCs) at Geisinger's Community Medicine Service Line (CMSL) clinics. The study will compare patients who receive follow-up outreach from nurses after an ASC diagnosis with those who receive standard care. The purpose is to assess if nurse contact via calls or patient portal messages affects emergency department use within seven days after the appointment. Participants will be randomly assigned to one of two groups. In the experimental group, nurses are prompted through the electronic health record system to provide follow-up outreach by phone calls and/or patient portal messages after the patient's appointment. The control group receives usual care, which may include no additional follow-up notifications. The study includes patients aged 30 and older and will continue until at least 4,330 patients are enrolled in each of three age groups: 30-45, 45-64, and 65 and older. During the study, researchers will monitor emergency department visits within one week after the appointment as the main outcome. The study uses an intent-to-treat analysis and will analyze results separately for each age group and combined. Participation involves receiving usual care or nurse outreach, with data collected through the electronic health record system. The study may also include interim data reviews and could end early based on clinical guidance. The total planned enrollment is approximately 12,990 patients.
CONDITIONS
Brief Title
CMSL Ambulatory Sensitive Condition Nudge Study 2
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 30 years or older
- Had a qualifying visit in CMSL with an ambulatory sensitive condition diagnosis
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Ongoing during study participation
Participants receive behavioral intervention where nurses may contact them through calls or portal messages to provide follow-up outreach after an ambulatory sensitive condition diagnosis.
Follow-up contacts as determined by nursing staff
Duration - 7 days post-appointment
Participants are monitored for emergency department visits within 7 days after their ambulatory sensitive diagnosis appointment.
1 follow-up assessment
Trial Site Locations
Total: 1 location
1
Geisinger
Danville, Pennsylvania, United States, 17821
Actively Recruiting
Research Team
A
Amir Goren, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here